Accelerate Diagnostics, Inc.
LSE: 0H8E.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Jack Phillips
- Employees
- 107
- Headquarters
- Tucson, United States
- IPO year
- 2018
- Market cap
- $25.0
- Website
- https://acceleratediagnostics.com
Loading 0H8E…
Loading profile data…Frequently asked questions about 0H8E
What does Accelerate Diagnostics, Inc. (0H8E.L) do?
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious...
Where does 0H8E.L trade?
Accelerate Diagnostics, Inc. (0H8E.L) trades on the London Stock Exchange.
What sector is 0H8E.L in?
Accelerate Diagnostics, Inc. (0H8E.L) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of Accelerate Diagnostics, Inc.?
Jack Phillips is the chief executive officer of Accelerate Diagnostics, Inc. (0H8E.L).
Where is Accelerate Diagnostics, Inc. headquartered?
Accelerate Diagnostics, Inc. is headquartered in United States.
Does 0H8E.L pay a dividend?
Accelerate Diagnostics, Inc. (0H8E.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0H8E.L go public?
Accelerate Diagnostics, Inc. (0H8E.L) completed its initial public offering in 2018.